spironolacton- ratiopharm 50mg tablett
ratiopharm gmbh - spironolaktoon - tablett - 50mg 50tk; 50mg 20tk
verospiron tablett
gedeon richter plc. - spironolaktoon - tablett - 25mg 20tk
verospiron kõvakapsel
gedeon richter plc. - spironolaktoon - kõvakapsel - 50mg 30tk
spirogamma 50 tablett
woerwag pharma gmbh & co. kg - spironolaktoon - tablett - 50mg 20tk; 50mg 50tk
spirix tablett
orifarm healthcare a/s - spironolaktoon - tablett - 50mg 20tk
qaialdo
nova laboratories ireland limited - spironolaktoon - edema; heart failure; liver cirrhosis; ascites; nephrotic syndrome; hyperaldosteronism; essential hypertension - antihypertensives and diuretics in combination - in the management of refractory oedema associated with congestive cardiac failure; hepatic cirrhosis with ascites and oedema, malignant ascites, nephrotic syndrome, diagnosis and treatment of primary aldosteronism, essential hypertension. neonates, children and adolescents should only be treated under guidance of a paediatric specialist (see sections 5. 1 ja 5.
spirix tablett
orifarm healthcare a/s - spironolaktoon - tablett - 25mg 20tk; 25mg 100tk; 25mg 60tk
spirocomp-ratiopharm tablett
ratiopharm gmbh - furosemiid+spironolaktoon - tablett - 20mg+50mg 100tk
spiro comp.-ratiopharm õhukese polümeerikattega tablett
merckle gmbh - furosemiid+spironolaktoon - õhukese polümeerikattega tablett - 20mg+50mg 100tk
lysodren
hra pharma rare diseases - mitotane - neerupealiste korteede neoplasmid - antineoplastilised ained - arenenud (retsidiivne, metastaatiline või retsidiivne) neerupealise koore kartsinoom sümptomaatiline ravi. mõju lysodren mitte-funktsionaalne neerupealise koore kartsinoom ei ole tuvastatud.